SproutNews logo

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC)

NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ:IRTC). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/irtc.

The investigation concerns whether iRhythm and certain of its officers and/or directors have violated federal securities laws.

On November 13, 2019, iRhythm filed a Notification of Late Filing with the U.S. Securities and Exchange Commission, stating that "[a]s part of the Company's efforts to remediate its previously disclosed material weaknesses, the Company identified errors affecting prior periods in the course of preparing the Form 10-Q that require further analysis." iRhythm further advised investors that "[t]hese errors may result in the correction of previously issued annual and quarterly financial statements" and "the error evaluation will include the assessment of any additional control deficiencies." On this news, iRhythm's stock price fell sharply during intraday trading on November 13, 2019.

If you are aware of any facts relating to this investigation, or purchased iRhythm shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/irtc. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 566388

Go Top